查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1584131

免疫毒素市場，按類型、交付方式、目標適應症、最終用戶、國家和地區 - 2024-2032年產業分析、市場規模、市場佔有率和預測

Immunotoxins Market, By Type, By Delivery Method, By Target Indication, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年免疫毒素市場規模為1.429億美元，2024年至2032年年複合成長率為8.90%。

免疫毒素市場-市場動態

增加對研究和戰略合作夥伴關係的投資推動薄膜電容器市場的創新

對研究和戰略合作夥伴關係的不斷增加的投資大幅推動了免疫毒素市場的創新，Amgen和Genentech等主要製藥公司每年撥款數十億美元來開發靶向癌症療法。據美國國家癌症研究所表示，2021年美國新診斷出約 190萬癌症病例，凸顯了創新治療的迫切需求。AstraZeneca和Merck之間合作推進抗體藥物偶聯物技術對於提高治療效果非常重要。此外，歐盟的「地平線2020」計劃資助了許多致力於免疫毒素的研究計劃，進一步鞏固了該行業的成長。隨著這些合作的不斷蓬勃發展，預計將導致新型免疫毒素的開發，改善患者的治療效果並擴大治療選擇。

免疫毒素市場 - 關鍵見解

根據研究分析師分享的分析，預計全球市場在預測期內（2024-2032年）每年將以 8.90%左右的年複合成長率成長

根據類型細分，預計單株抗體免疫毒素將在2023年顯示出最大的市場佔有率

根據給藥方法細分，系統給藥是2023年的主導類型

根據目標適應症細分，血液系統惡性腫瘤是2023年的主導類型

依地區分類，北美是2023年的主要收入來源

免疫毒素市場-細分分析：

全球免疫毒素市場根據類型、遞送方法、目標適應症、最終用戶和區域進行細分。

市場根據類型分為三類：重組免疫毒素、嵌合抗原受體（CAR）T 細胞療法和單株抗體免疫毒素。基於單株抗體的免疫毒素因其在標靶治療中的既定功效而佔據最高的市場佔有率，其次是重組免疫毒素，它提供了創新的治療選擇。嵌合抗原受體（CAR）T細胞療法排名第三，顯示出巨大的潛力。

根據交付方式，市場分為兩類：系統管理和本地管理。全身給藥因其能夠有效治療廣泛的癌症而被優先考慮，而局部給藥則緊隨其後，提供副作用較少的標靶治療。兩種方法都能滿足不同的治療需求和患者狀況，進而增強治療選擇。

免疫毒素市場 - 地理洞察

免疫毒素市場的地理模式揭示了北美、歐洲和亞太地區的重要活動，每個活動都對市場動態做出了獨特的貢獻。北美，尤其是美國，由於先進的醫療基礎設施、高額研發投資以及Amgen和Genentech等大型製藥公司的存在，在市場佔有率方面處於領先地位。美國國家癌症研究所強調了一系列強大的免疫毒素療法，顯示該地區進行臨床試驗和創新。歐洲也是一個關鍵參與者，受到對先進療法的監管支持和對精準醫療日益重視的推動，德國和英國等國家取得了顯著的發展。同時，在癌症盛行率上升和醫療保健普及的推動下，亞太地區成為一個充滿前景的市場，特別是在中國和印度等國家，這些國家的政府投資生物技術研究。本地公司和國際公司之間的合作進一步增強了該地區的市場潛力，為全球免疫毒素療法的進步做出了貢獻。

免疫毒素市場-競爭格局：

免疫毒素市場競爭格局的特點是成熟的製藥公司和創新的生物技術公司混合在一起，所有這些公司都透過研究、開發和策略合作來爭奪市場佔有率。Amgen、Genentech和Eli Lilly等主要參與者利用其在腫瘤學方面的豐富資源和專業知識，積極參與免疫毒素療法的開發和商業化。例如，Amgen公司 FDA 批准的免疫毒素 blinatumomab（Blincyto）為治療某些類型的白血病設定了基準，說明了這種治療方法的潛力。新興的參與者，如ImmunoGen和StemSynergy Therapeutics，也在利用獨特的免疫毒素候選物和新穎的遞送機制方面取得了長足的進步，促進了創新和競爭壓力。合作在這個市場上很常見；例如，生物技術公司和學術機構之間的夥伴關係推動研究工作，開展探索免疫毒素新應用和組合的臨床試驗。這種充滿活力的環境得到了生物技術研究增加投資和對個人化醫療的重視的進一步支持，使免疫毒素市場實現持續成長和進步。

最新進展：

2024年 4月，Invera Inc. 和 Astellas Pharma 宣布合作開發治療性雙特異性抗體。Astellas Pharma將利用 Invera 的B-Body 雙特異性抗體平台來推進其雙特異性治療應用的研究。

2023年1月，List Biological Labs, Inc. 透過整合新型500L 生物反應器和切向流過濾系統，增強了其細菌治療藥物的製造能力，目的是提高生產效率並滿足對細菌治療藥物不斷成長的需求。

目錄

第1章 免疫毒素市場概述

  • 研究範圍
  • 市場預估年份

第2章 執行摘要

  • 市場摘錄
    • 依類型分類的免疫毒素市場摘錄
    • 依輸送方式分類的免疫毒素市場摘錄
    • 依目標指示分類的免疫毒素市場摘錄
    • 依最終用戶的免疫毒素市場摘錄
    • 依國家/地區分類的免疫毒素市場摘錄
    • 依地區分類的免疫毒素市場摘錄
  • 競爭洞察

第3章 免疫毒素主要市場趨勢

  • 免疫毒素市場促進因素
    • 市場促進因素的影響分析
  • 免疫毒素市場限制
    • 市場限制影響分析
  • 免疫毒素市場機會
  • 免疫毒素市場未來趨勢

第4章 免疫毒素產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章 免疫毒素市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第6章 免疫毒素市場格局

  • 2023年免疫毒素市場佔有率分析
  • 依主要製造商分類的細分資料
    • 既有參與者分析
    • 新興參與者分析

第7章 免疫毒素市場 - 依類型

  • 概述
    • 依類型分類的細分市場佔有率分析
    • 重組免疫毒素
    • 嵌合抗原受體（CAR）T 細胞療法
    • 基於單株抗體的免疫毒素

第8章 免疫毒素市場 - 依輸送方式

  • 概述
    • 依輸送方式分類的細分市場佔有率分析
    • 全身給藥
    • 局部管理

第9章 免疫毒素市場 - 依目標指示

  • 概述
    • 依目標指示分類的細分市場佔有率分析
    • 實體腫瘤
    • 血液系統惡性腫瘤
    • 自體免疫疾病

第10章 免疫毒素市場 - 依最終用戶

  • 概述
    • 依最終用戶分類的細分市場佔有率分析
    • 醫院
    • 癌症研究機構
    • 專科診所

第11章 免疫毒素市場 - 依地理位置

  • 介紹
    • 依地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美免疫毒素主要製造商
    • 北美市場規模和預測（依國家）
    • 北美市場規模和預測（依類型）
    • 北美市場規模和預測（依輸送方式）
    • 北美市場規模和預測（依目標指示）
    • 北美市場規模和預測（依最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲免疫毒素主要製造商
    • 歐洲市場規模和預測（依國家）
    • 歐洲市場規模與預測（依類型）
    • 歐洲市場規模和預測（依輸送方式）
    • 歐洲市場規模和預測（依目標指示）
    • 歐洲市場規模和預測（依最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區（APAC）
    • 概述
    • 亞太地區免疫毒素主要製造商
    • 亞太地區市場規模與預測（依國家）
    • 亞太地區市場規模與預測（依類型）
    • 亞太地區市場規模與預測（依輸送方式）
    • 亞太地區市場規模與預測（依目標指示）
    • 亞太地區市場規模和預測（依最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲免疫毒素主要製造商
    • 拉丁美洲市場規模與預測（依國家）
    • 拉丁美洲市場規模與預測（依類型）
    • 拉丁美洲市場規模和預測（依輸送方式）
    • 拉丁美洲市場規模和預測（依目標指示）
    • 拉丁美洲市場規模和預測（依最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲免疫毒素主要製造商
    • 中東和非洲市場規模及預測（依國家）
    • 中東和非洲市場規模及預測（依類型）
    • 中東和非洲市場規模及預測（依輸送方式）
    • 中東和非洲市場規模及預測（依目標指示）
    • 中東和非洲市場規模和預測（依最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA其他

第12章 主要供應商分析 - 免疫毒素產業

  • 競爭儀表板
  • 公司簡介
    • Amgen Inc.
    • AstraZeneca PLC
    • Bayer AG
    • Daiichi Sankyo Company, Limited
    • Eisai Co., Ltd.
    • Eli Lilly and Company
    • Genentech, Inc.
    • Immunomedics, Inc.（Gilead Sciences）
    • Johnson & Johnson
    • Merck & Co., Inc.
    • Novartis AG
    • Pfizer Inc.
    • Roche Holding AG
    • Sanofi SA
    • Seattle Genetics, Inc.
    • Takeda Pharmaceutical Company Limited
    • Others

第13章 360 度分析師視角

第14章 附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4093

REPORT HIGHLIGHT

Immunotoxins Market size was valued at USD 142.90 Million in 2023, expanding at a CAGR of 8.90% from 2024 to 2032.

The Immunotoxins market, which focuses on targeted therapies combining antibodies with cytotoxic agents to selectively kill cancer cells, is gaining momentum due to the increasing prevalence of cancer and autoimmune diseases. With an estimated 1.9 million new cancer cases expected in the U.S. alone in 2024, the demand for effective treatments is on the rise. This growing need is spurred by advancements in biotechnology, leading to the development of more effective immunotoxin formulations that enhance therapeutic efficacy while minimizing side effects. However, challenges such as high production costs and stringent regulatory approvals can hinder market growth. Moreover, the complexity of immunotoxin mechanisms can lead to variability in patient responses, raising concerns about treatment consistency. Nevertheless, the expanding research pipeline and the exploration of combination therapies present significant opportunities for market expansion. Companies are increasingly investing in clinical trials and strategic collaborations to innovate and diversify their product offerings, positioning themselves to meet the evolving needs of patients and healthcare providers in the oncology landscape.

Immunotoxins Market- Market Dynamics

Increasing Investment in Research and Strategic Partnerships Fuels Innovation in the Film Capacitor Market

The increasing investment in research and strategic partnerships is significantly driving innovation in the immunotoxins market, with major pharmaceutical companies like Amgen and Genentech allocating billions annually to develop targeted cancer therapies. According to the National Cancer Institute, approximately 1.9 million new cancer cases were diagnosed in the U.S. in 2021, underscoring the urgent need for innovative treatments. Collaborations such as the partnership between AstraZeneca and Merck to advance antibody-drug conjugate technology are pivotal in enhancing therapeutic efficacy. Moreover, the European Union's Horizon 2020 program has funded numerous research initiatives focusing on immunotoxins, further solidifying the sector's growth. As these collaborations continue to flourish, they are expected to lead to the development of novel immunotoxins that improve patient outcomes and expand treatment options.

Immunotoxins Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.90% over the forecast period (2024-2032)

Based on Type segmentation, Monoclonal Antibody-Based Immunotoxins were predicted to show maximum market share in the year 2023

Based on Delivery Method segmentation, Systemic Administration was the leading type in 2023

Based on Target Indication segmentation, Hematologic Malignancies was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Immunotoxins Market- Segmentation Analysis:

The Global Immunotoxins Market is segmented on the basis of Type, Delivery Method, Target Indication, End-User, and Region.

The market is divided into three categories based on Type: Recombinant Immunotoxins, Chimeric Antigen Receptor (CAR) T-cell therapy, and Monoclonal Antibody-Based Immunotoxins. Monoclonal Antibody-Based Immunotoxins hold the highest market share due to their established efficacy in targeted therapies, followed by Recombinant Immunotoxins, which offer innovative treatment options. Chimeric Antigen Receptor (CAR) T-cell therapy ranks third, showcasing significant potential.

The market is divided into two categories based on the Delivery Method: Systemic Administration and Local Administration. Systemic Administration is prioritized due to its ability to treat widespread cancers effectively, while Local Administration follows, offering targeted treatment with fewer side effects. Both methods cater to different therapeutic needs and patient profiles, enhancing treatment options.

Immunotoxins Market- Geographical Insights

The geographical landscape of the Immunotoxins market reveals significant activity across North America, Europe, and Asia-Pacific, each contributing uniquely to market dynamics. North America, particularly the United States, leads in market share due to advanced healthcare infrastructure, high investment in research and development, and the presence of major pharmaceutical companies like Amgen and Genentech. The National Cancer Institute has highlighted a robust pipeline of immunotoxin therapies, indicating ongoing clinical trials and innovations in this region. Europe is also a key player, driven by regulatory support for advanced therapies and a growing emphasis on precision medicine, with notable developments in countries like Germany and the UK. Meanwhile, the Asia-Pacific region is emerging as a promising market, fueled by increasing cancer prevalence and expanding healthcare access, particularly in countries like China and India, where governments are investing in biotechnology research. Collaborative efforts between local firms and international companies further enhance the market potential in this region, contributing to the global advancement of immunotoxin therapies.

Immunotoxins Market- Competitive Landscape:

The competitive landscape of the Immunotoxins market is characterized by a mix of established pharmaceutical companies and innovative biotech firms, all vying for market share through research, development, and strategic collaborations. Major players such as Amgen, Genentech, and Eli Lilly are actively involved in developing and commercializing immunotoxin therapies, leveraging their extensive resources and expertise in oncology. For instance, Amgen's FDA-approved immunotoxin, blinatumomab (Blincyto), has set a benchmark in treating certain types of leukemia, illustrating the potential of this therapeutic approach. Emerging players, like ImmunoGen and StemSynergy Therapeutics, are also making strides with unique immunotoxin candidates and novel delivery mechanisms, fostering innovation and competitive pressure. Collaborations are common in this market; for example, partnerships between biotech firms and academic institutions are driving research efforts, leading to clinical trials that explore new applications and combinations of immunotoxins. This dynamic environment is further supported by increasing investments in biotechnology research and an emphasis on personalized medicine, positioning the Immunotoxins market for continued growth and advancement.

Recent Developments:

In April 2024, Invera Inc. and Astellas Pharma announced a collaboration to develop therapeutic bispecific antibodies. Astellas Pharma will utilize Invera's B-Body bispecific antibody platform to advance its research in bispecific therapeutic applications.

In January 2023, List Biological Labs, Inc. enhanced its bacterial therapeutic manufacturing capabilities by incorporating a new 500L bioreactor along with a tangential flow filtration system, aimed at increasing production efficiency and meeting growing demand for bacterial therapeutics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IMMUNOTOXINS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Amgen Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Daiichi Sankyo Company, Limited
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • Genentech, Inc.
  • Immunomedics, Inc. (Gilead Sciences)
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Roche Holding AG
  • Sanofi S.A.
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited
  • Others

GLOBAL IMMUNOTOXINS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Recombinant Immunotoxins
  • Chimeric Antigen Receptor (CAR) T-Cell Therapy
  • Monoclonal Antibody-Based Immunotoxins

GLOBAL IMMUNOTOXINS MARKET, BY DELIVERY METHOD- MARKET ANALYSIS, 2019 - 2032

  • Systemic Administration
  • Local Administration

GLOBAL IMMUNOTOXINS MARKET, BY TARGET INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Solid Tumors
  • Hematological Malignancies
  • Autoimmune Diseases

GLOBAL IMMUNOTOXINS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Cancer Research Institutes
  • Specialty Clinics

GLOBAL IMMUNOTOXINS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Immunotoxins Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Immunotoxins Market Snippet by Type
    • 2.1.2. Immunotoxins Market Snippet by Delivery Method
    • 2.1.3. Immunotoxins Market Snippet by Target Indication
    • 2.1.4. Immunotoxins Market Snippet by End-User
    • 2.1.5. Immunotoxins Market Snippet by Country
    • 2.1.6. Immunotoxins Market Snippet by Region
  • 2.2. Competitive Insights

3. Immunotoxins Key Market Trends

  • 3.1. Immunotoxins Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Immunotoxins Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Immunotoxins Market Opportunities
  • 3.4. Immunotoxins Market Future Trends

4. Immunotoxins Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Immunotoxins Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Immunotoxins Market Landscape

  • 6.1. Immunotoxins Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Immunotoxins Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Recombinant Immunotoxins
    • 7.1.3. Chimeric Antigen Receptor (CAR) T-Cell Therapy
    • 7.1.4. Monoclonal Antibody-Based Immunotoxins

8. Immunotoxins Market - By Delivery Method

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Delivery Method, 2023 & 2032 (%)
    • 8.1.2. Systemic Administration
    • 8.1.3. Local Administration

9. Immunotoxins Market - By Target Indication

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Target Indication, 2023 & 2032 (%)
    • 9.1.2. Solid Tumors
    • 9.1.3. Hematological Malignancies
    • 9.1.4. Autoimmune Diseases

10. Immunotoxins Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Cancer Research Institutes
    • 10.1.4. Specialty Clinics

11. Immunotoxins Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Immunotoxins Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Immunotoxins Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Immunotoxins Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Immunotoxins Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Immunotoxins Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Immunotoxins Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Amgen Inc.
    • 12.2.2. AstraZeneca PLC
    • 12.2.3. Bayer AG
    • 12.2.4. Daiichi Sankyo Company, Limited
    • 12.2.5. Eisai Co., Ltd.
    • 12.2.6. Eli Lilly and Company
    • 12.2.7. Genentech, Inc.
    • 12.2.8. Immunomedics, Inc. (Gilead Sciences)
    • 12.2.9. Johnson & Johnson
    • 12.2.10. Merck & Co., Inc.
    • 12.2.11. Novartis AG
    • 12.2.12. Pfizer Inc.
    • 12.2.13. Roche Holding AG
    • 12.2.14. Sanofi S.A.
    • 12.2.15. Seattle Genetics, Inc.
    • 12.2.16. Takeda Pharmaceutical Company Limited
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us